KANATA, Ontario, June 24, 2015 /PRNewswire/ -- BRAEBON Medical Corporation announces today that the DentiTrac® oral appliance compliance system has passed a substantial regulatory hurdle and is now FDA cleared in the USA for use with the SomnoDent oral device. BRAEBON congratulates SomnoMed for being the first company in the world to achieve this milestone.
Photo - http://photos.prnewswire.com/prnh/20150624/225428
Logo - http://photos.prnewswire.com/prnh/20150624/225429LOGO
The DentiTrac® system has been developed by BRAEBON. It is a wearable micro-recorder and web cloud portal combination which defines the new gold standard for the objective measurement of oral appliance compliance measurement for sleep apnea. DentiTrac® is an integrated wearable micro-recorder embedded inside an oral appliance to reliably and accurately gather detailed information to confirm a patient is following prescribed therapy. The information is then uploaded to the BRAEBON cloud portal where dental and medical specialists can conveniently and securely review patient information and assess sleep apnea therapy adherence.
“We are very pleased DentiTrac® is launching in the US market. Accurate oral appliance compliance measurement is needed to level the playing field with traditional sleep apnea treatment called CPAP. In addition, the ability to reliably measure sleep apnea treatment adherence is a vital requirement for insurance payers. Continuous Open Airway Therapy (COAT) is the number one alternative to CPAP and we anticipate this will contribute to significant overall growth in the burgeoning field of dental sleep medicine and the use of oral appliance therapy for sleep apnea. The DentiTrac® is the final realization of our Test Treat Trac strategy which empowers clinicians across multiple disciplines to efficiently and collaboratively work together to more effectively manage the sleep apnea patient,” said Dr. Richard Bonato, CEO and Co-Founder.
“The challenge was to develop a measurement technology which could not be easily deceived. This was vital because new US Federal DOT legislation will impact everyone in the transportation industry including all truck drivers, pilots, bus drivers, etc. We had to invent a novel and powerful solution which we’ve secured with IP patent protection. The level of product sophistication connected with our cloud portal is beyond anything we’ve done before. I’m very proud of what our team has accomplished,” said Donald Bradley, CTO and Co-Founder.
BRAEBON has an agreement in place with SomnoMed Limited as the preferred worldwide dorsal fin oral appliance design and for exclusive distribution in the EU and parts of Australasia. At this time, the BRAEBON DentiTrac compliance system is only available from SomnoMed in the USA.
About BRAEBON Medical Corporation
BRAEBON is a privately held Canadian corporation and has been in business since 1998 developing and manufacturing medical devices for snoring and sleep apnea in their ISO 13485 manufacturing facility. BRAEBON’s products are sold worldwide for use in the Sleep Medicine and Dental Sleep Medicine fields. BRAEBON is a world leader in portable home sleep apnea testing devices with its MediByte® and MediByte Jr.® recorders as well as its line of sleep sensors and accessories. For additional information contact Mr. Mitch Livingston, VP Business Development, by telephone at 613.831.6690 x220, via email, or visit BRAEBON at www.braebon.com. Join us BRAEBON (@braebon) | Twitter
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-gold-standard-in-wearable-compliance-measurement-receives-fda-clearance-300104259.html
SOURCE BRAEBON Medical Corporation
Help employers find you! Check out all the jobs and post your resume.